Track topics on Twitter Track topics that are important to you
9850 Genesee Ave.Suite 880
United States of America
Phone: (858) 450-1555
"Paul, Paul, slow down. I've spent my whole lifetime studying the brain, and not in my lifetime, and probably not in your lifetime will we understand how the brain works."
LONDON (dpa-AFX) - Vectura Group plc (VEC.L) said that it appointed Paul Fry as Chief Financial Officer and Executive Director with effect from 29 October 2018. Paul succeeds Andrew Derodra who, a...
Steve Paul has been appointed CEO of US biotech Karuna, to lead development of the psychiatric drug xanomeline, a previously shelved project that he helped to develop at Eli Lilly in the 1990s. Paul ...
Former Voyager Therapeutics (NASDAQ: VYGR) CEO Steven Paul has been tapped to run Boston-based Karuna Pharmaceuticals, a PureTech Health company that just raised $42 million this month. Karuna is deve...
In this episode of PharmaTelevision News Review, Fintan Walton talks with Ken MacLeod, Partner at Paul Capital Partners. Filmed at BioTrinity 2010 in Newbury, UK.
In this episode of PharmaTelevision News Review, Fintan Walton talks to Paul Anderson, Managing Director of OrthoCell.
Paul Offit responds to a column in the New York Times that claims there is a 'conspiracy of silence' among vaccine scientists about the harms of vaccines. Medscape Infectious Diseases
After one year in the role of chief executive of the Royal Pharmaceutical Society, Paul Bennett reflects on his first year in office and the Society’s plans moving forward.
3M™ Skin and Nasal Antiseptic(Povidone-Iodine Solution 5% w/w (0.5% available iodine) USP)
Nexcare™ Cold Sore Treatment
Avagard D Instant Hand Antiseptic with Moisturizers
This study looks at the difference in surgical scar outcomes between two different surgical incision methods during thyroid surgery: scalpel vs electrocautery. Patients who are already sch...
The purpose of this study is to evaluate the effectiveness of the GI clinic's currently used web-based instructions at St. Paul's Hospital.
In oncology, anemia is a frequent symptom, leading to complication of patient management for, more or less, a long term but often poorly evaluated by medical teams. In oncology, anemia is...
To continue surveillance of cardiovascular disease risk factors in the seven-county area of Minneapolis-St. Paul.
To continue surveillance of coronary heart disease (CHD) mortality and morbidity in the seven county metropolitan Minneapolis/St. Paul (Twin Cities) areas.
Paul Chasan, M.D. graduated Magna Cum Laude from Creighton University School of Medicine in Omaha, Nebraska. He completed his general surgical residency at the University of California, San Diego Medi...
Through its funds, Paul Capital Healthcare is one of the largest dedicated healthcare investors globally, with more than $1.6 billion in equity capital commitments and debt facilities under management...
The Paul-Ehrlich-Institut was founded on 1st June 1896 as Institut für Serumforschung und Serumprüfung (Institute for Serum Research and Serum Testing) at Steglitz near Berlin as a test and research...
To obtain illustrations, more information, or to conduct interviews with Capillary principals or Dr. Jeffrey Joseph, contact Paul Williams at email@example.com ...
ROKiT is a humanity first telecommunications business that offers consumers state of the art mobile handsets and wireless connectivity at an unbeatable value. As part of the ROK G...
We have published hundreds of Dr. Paul Chasan news stories on BioPortfolio along with dozens of Dr. Paul Chasan Clinical Trials and PubMed Articles about Dr. Paul Chasan for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dr. Paul Chasan Companies in our database. You can also find out about relevant Dr. Paul Chasan Drugs and Medications on this site too.
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...